A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
Applying to 3652, Vanderbilt Therapeutics (VT) CRS · Nashville, Tennessee
Answer a few short questions to share with the research team.